Propranolol
DrugOne administration of propranolol, once a week during six weeks. Reading by the participant of his/her traumatic story, 75 minutes (+/- 15 min) after propranolol intake.
NCT Number: NCT04950426
The aim of the study is to demonstrate a significant improvement in quality of life specific to patients with fibromyalgia syndrome in patients with fibromyalgia syndrome with comorbid posttraumatic stress disorder, treated with reconsolidation blockade.
Patients receive a treatment with propranolol associated with reconsolidation blockade of traumatic story once a week during 6 weeks, with evaluation at inclusion and at 3 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Centre Hospitalier Henri Laborit, Poitiers, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One administration of propranolol, once a week during six weeks. Reading by the participant of his/her traumatic story, 75 minutes (+/- 15 min) after propranolol intake.
Time frame: 3 months
Modification in quality of life in patients with fibromyalgia syndrome measured by the Fibromyalgia Impact Measurement Questionnaire (FIQ).
FIQ minimal value:0 (minimum impact) FIQ maximal value: 100 (maximal impact)
Centre Hospitalier Henri Laborit
Other
Acronym: PTSD-FMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07708948
Fibromyalgia, Fibromyalgia Syndrome
Beijing, Beijing Municipality, China
View Trial DetailsNCT07685379
Fibromyalgia, Fibromyalgia Syndrome
Belgrade, Serbia
View Trial DetailsNCT07591766
Behavior, Fibromyalgia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07577102
Fibromyalgia, Fibromyalgia Syndrome
Istanbul, Turkey (Türkiye)
View Trial Details